Similarly, in vitro studies on HNSCC cell lines focused mostly on SMO inhibition, with no studies examining potential non-canonical downstream activation of GLI transcription factors and downstream inhibition. This evidence concerns the gene GLI1 and head and neck squamous cell carcinoma.